多途径给药中医综合治疗慢性盆腔炎临床疗效观察  

Clinical efficacy observation of comprehensive treatment of chronic pelvic inflammatory disease by multi-route administration of traditional Chinese medicine

作　　者：聂雯雯 NIE Wenwen(Jiamusi Maternal and Child Health Hospital, Jiamusi Heilongjiang 154000, China)

机构地区：[1]黑龙江省佳木斯市妇幼保健院,黑龙江佳木斯154000

出　　处：《中国民康医学》2018年第23期61-62,共2页Medical Journal of Chinese People’s Health

摘　　要：目的:探讨多途径给药中医综合治疗在慢性盆腔炎中的应用效果。方法:选取136例慢性盆腔炎患者为研究对象,根据随机数表法分为观察组(多途径给药中医综合治疗)和对照组(常规药物治疗)各68例,观察两组患者的疗效、不良反应及复发率。结果:观察组患者的治疗有效率(97.06%)明显高于对照组(77.94%),而不良反应发生率(2.94%)和复发率(0)明显低于对照组(16.18%,11.76%),差异均有统计学意义(P<0.05)。结论:慢性盆腔炎患者使用多途径给药中医综合治疗效果优于常规药物治疗,能够有效改善患者的临床症状,减少不良反应的发生率和疾病复发率,是一种良好的治疗选择。Objective:To explore effects of comprehensive treatment of chronic pelvic inflammatory disease by multi-route administration of traditional Chinese medicine(TCM).Methods:136patients with chronic pelvic inflammatory disease were selected as the research objects and divided into observation group(68cases,multi-route Chinese medicine comprehensive treatment)and control group(68cases,conventional drug treatment).The efficacy,adverse reactions and recurrence rate were observed between the two groups.Results:The effective rate in the observation group(97.06%)was significantly higher than that in the control group(77.94%),the incidence of adverse reactions(2.94%)and recurrence rate(0)were significantly lower than those in the control group(16.18%,11.76%).,and the differences were statistically significant(P<0.05).Conclusions:The comprehensive treatment of chronic pelvic inflammatory disease by the multi-route administration of TCM is superior to the conventional drug treatment.It can effectively improve the clinical symptoms of the patients,and reduce the incidence of adverse reactions and the recurrence rate.Therefore,it is a good treatment option.

关 键 词：多途径给药 中医综合治疗 慢性盆腔炎 

分 类 号：R711.33[医药卫生—妇产科学]